Compare Rollins Inc. Common Stock (ROL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rollins Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Rollins Inc. Common Stock trades at $32.97 (market cap $15.47B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Rollins Inc. Common Stock is far larger — about 8.6× Vir Biotechnology Inc. Common Stock's market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rollins Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| ROL | VIR | |
|---|---|---|
Market Cap | $15.47B | $1.80B |
Volume | 6,712,154 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $65.60 | $11.78 |
52-Week Low | $29.69 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $16.48B | $1.36B |
Dividend Yield | 2.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Rollins Inc. Common Stock
Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
